Related Experiment Video
Updated: Jun 9, 2026

14:39
A Quantitative Assay for Insulin-expressing Colony-forming Progenitors
Published on: November 28, 2011
14.1K
A Real Time Quaking Induced Conversion (RT-QuIC) Assay for Detection of Misfolded Insulin Protein
Jessica M Alderiso1, Rafael Hernandez LaTorre1, Trisha M Cox2
1Touro University College of Osteopathic Medicine-Montana.
Biorxiv : the Preprint Server for Biology
|April 17, 2026
Summary
Researchers developed a novel assay to detect misfolded insulin, crucial for blood glucose regulation. This new method, Real-time Quaking-Induced Conversion (RT-QuIC), shows promise for understanding aging and metabolic diseases linked to protein misfolding.
Area of Science:
- Biochemistry
- Molecular Biology
- Metabolic Disease Research
Background:
- Protein misfolding is implicated in aging and disease, but its role in metabolic dysfunction remains unclear.
- Insulin, essential for glucose regulation, can misfold, potentially contributing to metabolic disorders.
Purpose of the Study:
- To develop and validate a Real-time Quaking-Induced Conversion (RT-QuIC) assay for detecting misfolded insulin.
- To explore the potential of this assay in studying insulin aggregation in metabolic disease models.
Main Methods:
- Adaptation of the RT-QuIC assay, originally for prions, to detect misfolded insulin.
- Validation using recombinant insulin and clinical insulin aggregates.
- Application of the assay to tissue samples from a mouse model of metabolic disease.
Main Results:
- Successful adaptation and validation of the RT-QuIC assay for misfolded insulin detection.
- Characterization of insulin aggregates from clinical devices revealed structural differences.
- Demonstrated proof-of-concept for using the RT-QuIC assay in a metabolic disease mouse model.
Conclusions:
- The developed RT-QuIC assay provides a novel tool for studying insulin aggregation.
- This assay has potential for early detection and understanding of metabolic disorders linked to aging and disease.
- Further research may uncover new therapeutic targets for metabolic dysfunction.

